The biopharmaceutical industry is aiming for a 2025 reversal of last year's slump in investor returns but remains wary over ...

The cancer therapeutics market is set to exceed $400 billion. Read why five pharmaceutical companies offer attractive ...

The Indian pharmaceutical market (IPM) has returned to negative volume growth this Q3FY25 after two consecutive quarters of ...

Major moves in the pharmaceutical industry include Ownership Matters recommending support for the Chemist Warehouse-Sigma Healthcare merger, J&J's potential bid for Intra-Cellular Therapies, and ...

The government has proposed extending the compliance deadline for revised Schedule M norms for pharmaceutical manufacturing.

Drugmakers have started 2025, implementing price hikes for 583 products within the first two days of the new year alone, ...

Overall, biopharma layoffs rose ever so slightly in 2024 compared to the year before, though the number of layoff rounds ...

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research ...

Zlata Pharma LLP hosted a memorable event to mark the launch of its new wellness product range, marking a significant ...

The Indian pharmaceutical market sees negative volume growth in Q3FY25 but benefits from strong pricing and new product ...

The Indian pharma sector faces a significant question as the US gears up for a change in administration with Donald Trump set ...